If academic discoveries turn out to be wrong, one drug company wants its money back.
That’s the tough-minded proposal floated today by the chief medical officer of Merck & Co., one of the world’s 10 largest drug companies, as a way to fix the “reproducibility crisis,” or how many, if not most, published scientific reports turn out to be incorrect.
{iframe}https://www.technologyreview.com/s/601348/merck-wants-its-money-back-if-university-research-is-wrong/#/set/id/601350/{/iframe}